Figure 1
Figure 1. Toxicity of nonmyeloablative conditioning regimens. Mice were conditioned with chemotherapeutic agents or TBI as described in “Materials and methods.” (A) White blood cell counts in mice conditioned with 2 Gy TBI (▵), 2 Gy TBI + 200 mg/kg CY (□), 200 mg/kg CY (◇), 90 mg/kg FLU + 200 mg/kg CY (▿), 20 mg/kg BU (●), and 35 mg/kg BU (♦). TBI (5.5 Gy, ○) is shown for comparison. BU + CY groups were omitted for clarity as they closely resembled the CY-only group. (B) Mean number of days to recovery of granulocytes to more than 500 per mm3. (C) Platelet counts for BU- and BU + CY-treated mice. (D) CD3+ T-cell counts (solid line) as well as the percentage of CD4+ and CD8+ subpopulations of CD3+ cells were followed by flow cytometry after conditioning with 35 mg/kg BU. (E) Percent donor chimerism measured by flow cytometry of eGFP+ donor cells in the peripheral blood following HSCT.

Toxicity of nonmyeloablative conditioning regimens. Mice were conditioned with chemotherapeutic agents or TBI as described in “Materials and methods.” (A) White blood cell counts in mice conditioned with 2 Gy TBI (▵), 2 Gy TBI + 200 mg/kg CY (□), 200 mg/kg CY (◇), 90 mg/kg FLU + 200 mg/kg CY (▿), 20 mg/kg BU (●), and 35 mg/kg BU (♦). TBI (5.5 Gy, ○) is shown for comparison. BU + CY groups were omitted for clarity as they closely resembled the CY-only group. (B) Mean number of days to recovery of granulocytes to more than 500 per mm3. (C) Platelet counts for BU- and BU + CY-treated mice. (D) CD3+ T-cell counts (solid line) as well as the percentage of CD4+ and CD8+ subpopulations of CD3+ cells were followed by flow cytometry after conditioning with 35 mg/kg BU. (E) Percent donor chimerism measured by flow cytometry of eGFP+ donor cells in the peripheral blood following HSCT.

Close Modal

or Create an Account

Close Modal
Close Modal